OptimizeRx(OPRX) - 2024 Q3 - Quarterly Results

Exhibit 99.1 OptimizeRx Reports Third Quarter 2024 Financial Results - Q3 revenue of $21.3 million, increasing 30% year-over-year - Q3 gross profit increased 37% year-over-year to$ 13.4 million with a gross margin of 63% - Won 5 DAAP deals during Q3 WALTHAM, Mass. – November 13, 2024 – OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, reported results for the th ...